Artivion
AORT
239 hedge funds and large institutions have $1.63B invested in Artivion in 2026 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 94 increasing their positions, 66 reducing their positions, and 38 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
42% more repeat investments, than reductions
Existing positions increased: 94 | Existing positions reduced: 66
1.7% more ownership
Funds ownership: 91.02% → 92.72% (+1.7%)
0% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 38
1% less funds holding
Funds holding: 242 → 239 (-3)
17% less capital invested
Capital invested by funds: $1.97B → $1.63B (-$341M)
Top Buyers
Top Sellers
AORT Hedge Fund Activity: Q1 2026 in Review
239 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Artivion (AORT) for Q1 2026, worth a combined $1.63B — down 17% from $1.97B a quarter earlier.
Fund positioning in AORT was balanced in Q1 2026: 38 funds opened new positions, 38 closed out, 94 added to existing stakes and 66 trimmed.
The largest buyer was Conestoga Capital Advisors, opening a new position worth an estimated $46.4M. The largest seller was Invesco, cutting an estimated $28.6M.
- 239 institutional investors held Artivion (AORT) as of Q1 2026, down from 242 in Q4 2025.
- Funds reported $1.63B of Artivion stock for Q1 2026, down 17% quarter-over-quarter.
- 38 funds opened new Artivion positions in Q1 2026 and 38 closed out, a net change of 0 holders.
- The largest Artivion buyer in Q1 2026 was Conestoga Capital Advisors, an estimated $46.4M added.
- The largest Artivion seller in Q1 2026 was Invesco, an estimated $28.6M sold.
Based on aggregated 13F filings for Q1 2026.